Concepedia

Florian Voß

FV

Statistics

Publications

13

Citations

305

H-Index

11

Active since

2009

Affiliations

Boehringer Ingelheim (Germany)(Current)

German Center for Lung Research

Johannes Gutenberg University Mainz

University Medical Center of the Johannes Gutenberg University Mainz

Queen's University Belfast

Florian Voß is an author at Boehringer Ingelheim (Germany) specializing in pharmacotherapy, chronic obstructive pulmonary disease, and pulmonology.

ORCID

Publications per year

2009–2020

13

Publications

13

Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies

Dave Singh, Mina Gaga, Olaf Schmidt et al. · Respiratory Research · 2016 · 41 citations · Full text

, , +17

β-Blockers in COPD

François Maltais, Roland Buhl, Andrea Koch et al. · CHEST Journal · 2018 · 33 citations · Full text

The efficacy and safety of combined tiotropium and olodaterol via the Respimat<sup>®</sup> inhaler in patients with COPD: results from the Japanese sub-population of the Tonado<sup>®</sup> studies

Masakazu Ichinose, Hiroyuki Taniguchi, Ayako Takizawa et al. · International Journal of COPD · 2016 · 32 citations · Full text

, , +17

Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease

Roland Buhl, Sheldon Magder, Ulrich Bothner et al. · Respiratory Medicine · 2016 · 29 citations · Full text

, , +9

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

Klaus F. Rabe, David Halpin, MeiLan K. Han et al. · Respiratory Research · 2020 · 29 citations · Full text

, , +15

1–5 of 13